INNOCARE (09969) released its Monthly Return for the month ended 28 February 2026, reporting no adjustment to its authorised share capital of 25.00 billion shares at a par value of USD 0.000002, amounting to USD 50,000 in total. According to the document, the number of issued ordinary shares stood at 1,493.80 million, with 2.49 million treasury shares, maintaining a total of 1,496.28 million shares by month-end.

The company confirmed compliance with the relevant public float requirement, noting that the applicable threshold remains at 25%. There were no share repurchases or issuances in the period, and no treasury shares were transferred out during the month. Existing share incentive schemes recorded no new share issuance, leaving the previously disclosed maximum allocations unchanged.